
Loading, please wait...

Loading, please wait...

Hemipteran pests, such as aphids and leafhoppers, frequently cause significant damage to global agriculture. While Bacillus thuringiensis (Bt) proteins offer a sustainable solution, finding single-component proteins effective against these pests has remained a challenge. Recently, researchers conducted a comprehensive Bt protein safety assessment on Tpp78Aa, a novel insecticidal protein. This study signifies a major step toward developing transgenic crops that can safely resist hemipteran damage while maintaining a high safety profile for humans and non-target organisms.
The research successfully expanded the known insecticidal spectrum of Tpp78Aa. Specifically, the protein demonstrated high efficacy against two major pests: Sitobion avenae and Nephotettix cincticeps. Despite its potency against target insects, Tpp78Aa showed no acute toxicity to Apis mellifera, which is essential for preserving beneficial pollinators in the ecosystem.
Following international regulatory guidelines, the team performed an extensive allergenicity evaluation. Bioinformatics analysis showed no significant sequence homology between Tpp78Aa and any known allergens. Furthermore, integrated machine learning models categorized the protein as a non-allergen. These results are critical because they reduce concerns regarding the potential for adverse immune reactions in human populations.
In addition to allergenicity, the study assessed the physical stability of the protein. Researchers observed that Tpp78Aa degraded and became inactive rapidly when exposed to 100°C heat or simulated gastrointestinal fluids. This rapid breakdown suggests that the protein is unlikely to survive the human digestive process or food preparation temperatures. Consequently, this minimizes the risk of systemic exposure or unintended biological activity in consumers.
Moreover, the study evaluated the mammalian safety of Tpp78Aa using several human cell lines and erythrocyte models. Tpp78Aa exhibited no hemolytic activity against sheep or rabbit red blood cells. Additionally, it showed no significant cytotoxicity in 293T, Huh7, or Caco2 cell lines even after 72 hours of exposure. These findings collectively support the conclusion that the protein poses a low risk to mammalian health.
Hemipteran-specific insecticidal proteins like Tpp78Aa offer a targeted approach to pest management. By utilizing such proteins in transgenic crops, farmers can reduce their reliance on broad-spectrum chemical pesticides. This shift not only protects the environment but also enhances food security. The safety data provided by this study will support the regulatory approval and eventual commercialization of Tpp78Aa-expressing crops, marking a pivotal advancement in biotechnology.
Yes, based on current assessments, Tpp78Aa is classified as a non-allergen and shows no toxicity in human cell lines. It also degrades quickly in simulated stomach acid, reducing the risk of absorption.
No, the study specifically tested Tpp78Aa on Apis mellifera (honeybees) and found no acute toxicity, indicating that it is safe for these important pollinators.
It provides the first effective single-component Bt solution for hemipteran pests, which are notoriously difficult to control with traditional biological methods.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or clinical recommendations. Refer to the latest local and national guidelines for clinical practice.
References
Lu H et al. Food safety assessment of hemipteran-specific insecticidal protein Tpp78Aa from Bacillus thuringiensis. Pest Manag Sci. 2026 Apr 15. doi: 10.1002/ps.70772. PMID: 41986881.
Hammond BG et al. The food and environmental safety of Bt crops. Front Plant Sci. 2013;4:25. doi: 10.3389/fpls.2013.00025.
Koch MS et al. The food and environmental safety of Bt crops. Protein Expr Purif. 2015;105:23-28.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have evaluated the safety of Tpp78Aa, a novel insecticidal protein. Findings indicate low toxicity and allergenic risk for human consumption....
4 months ago

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today